 OncoSec Medical Incorporated NASDAQ: ONCS the Company or OncoSec, a company developing late-stage intratumoral cancer immunotherapies, today announced that Daniel J. OConnor, President and Chief Executive Officer will present at the BTIG Virtual Biotechnology Conference 2020 on Tuesday, August 11, 2020. 